Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-22T19:02:29.816Z Has data issue: false hasContentIssue false
  • English
  • Français

The relationship between potency of oxidative stress and severity of depression

Published online by Cambridge University Press:  24 June 2014

Medaim Yanik ,
Ozcan Erel  and
Mahmut Kati
Medaim Yanik*
Affiliation:
Department of Biochemistry, Research Hospital, Harran University, Sanliurfa, Turkey
Ozcan Erel
Affiliation:
Department of Biochemistry, Research Hospital, Harran University, Sanliurfa, Turkey
Mahmut Kati
Affiliation:
Department of Biochemistry, Research Hospital, Harran University, Sanliurfa, Turkey
*
Medaim Yanik, MD, Associate Professor, Harran University, Medical Faculty, Research Hospital, Department of Psychiatry, Sanliurfa TR-63100, Turkey. Tel: (90) 4143127976; Fax: (90) 4143151181; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Oxidative stress is one of the suggested mechanisms in major depression.

Objective:

To determine the oxidative and antioxidative status of plasma of patients with major depression and to investigate whether there is a relationship between the potency of oxidative stress and the severity of depression.

Methods:

To determine the antioxidative status of plasma, total and individual antioxidant levels which are total antioxidant potential (TAOP), total protein, albumin, uric acid, vitamin C and total bilirubin were measured. To determine the oxidative status, total peroxide level of plasma was measured in patients with drug-free depressive patients and compared with those of controls. Per cent ratio of total peroxide to TAOP was evaluated as oxidative stress index (OSI).

Results:

Plasma TAOP and individual antioxidant levels were found to be lower in patients with depression than those of controls. On the contrary, the patients had high total plasma peroxide levels. OSI values of the patients were significantly higher than those of controls (P = 0.002), and a significant positive correlation between Hamilton Depression Rating Scale (HDRS) and OSI values was found (r = 0.54, P = 0.01).

Conclusions:

The patients with major depression are exposed to oxidative stress, and OSI may be useful to reflect the severity of the disease.

Keywords

antioxidantdepressionHamilton Depression Rating Scaleoxidantoxidative stresstotal antioxidant
Type
Original Article
Information
Acta Neuropsychiatrica , Volume 16 , Issue 4 , August 2004 , pp. 200 - 203
Copyright
Copyright © 2004 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Halliwell, B, Gutteridge, JMC. Free radicals in biology and medicine. Oxford: Oxford Science Publications, 2000. Google Scholar
Savas, HA, Herken, H, Yurekli, Met al. Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology 2002;45: 57–61.DOI: 10.1159/000048677CrossRefGoogle ScholarPubMed
Yanik, M, Vural, H, Kocyigit, Aet al. Is the arginine–nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology 2003;47: 61–65.DOI: 10.1159/000070010CrossRefGoogle ScholarPubMed
Jesperger, JA, Richardson, JS. Oxygen free radicals and brain dysfunction. Intern J Neurosci 1991;57: 1–17. CrossRefGoogle Scholar
Sapolsky, RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000;48: 755–765.DOI: 10.1016/S0006-3223(00)00971-9CrossRefGoogle ScholarPubMed
Bilici, M, Efe, H, Koroglu, MA, Uydu, HA, Bekaroglu, M, Deger, O. Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments. J Affect Disord 2001;64: 43–51.CrossRefGoogle ScholarPubMed
Srivastava, N, Barthwal, MK, Dalal, PKet al. A study nitric oxide, β-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression. J Affect Disord 2002;72: 45–52.DOI: 10.1016/S0165-0327(01)00421-9CrossRefGoogle Scholar
Maes, M, Vos, ND, Pioli, Ret al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord 2000;58: 241–246.DOI: 10.1016/S0165-0327(99)00121-4CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington: American Psychiatric Association, 1994. Google Scholar
Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23: 56–62.CrossRefGoogle ScholarPubMed
Akdemir, A, Turkcapar, MG, Orsel, SD, Demirergi, N, Dag, I, Ozbay, MH. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr Psychiatry 2001;42: 161–165.DOI: 10.1053/comp.2001.19756CrossRefGoogle ScholarPubMed
Benzie, IF, Strain, JJ. The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay. Anal Biochem 1996;239: 70–76.CrossRefGoogle ScholarPubMed
Benzie, IF, Strain, JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant capacity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999;299: 15–27.CrossRefGoogle Scholar
Cao, G, Prior, RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998;44: 1309–1315.CrossRefGoogle ScholarPubMed
Schippinger, G, Wonisch, W, Abuja, PM, Fankhauser, F, Winklhofer-Roob, BM, Halwachs, G. Lipid peroxidation and antioxidant status in professional American football players during competition. Eur J Clin Invest 2002;32: 686–692.DOI: 10.1046/j.1365-2362.2002.01021.xCrossRefGoogle ScholarPubMed
Roob, JM, Khoschsorur, G, Tiran, A, Horina, JH, Holzer, H, Winklhofer-Roob, BM. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000;11: 539–549.CrossRefGoogle ScholarPubMed
Young, IS, Woodside, JV. Antioxidants in health and disease. J Clin Pathol 2001;54: 176–186.DOI: 10.1136/jcp.54.3.176CrossRefGoogle ScholarPubMed
Sheline, YI, Wang, PW, Gado, MH, Csernansky, JG, Vannier, MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996;93: 3908–3913 .DOI: 10.1073/pnas.93.9.3908CrossRefGoogle ScholarPubMed
Bremner, JD, Narayan, M, Anderson, ER, Staib, LH, Miller, HL, Charney, DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2001;158: 652–653.DOI: 10.1176/appi.ajp.158.4.652Google Scholar
Lee, AL, Ogle, WO, Sapolsky, RM. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord 2002;4: 117–128.DOI: 10.1034/j.1399-5618.2002.01144.xCrossRefGoogle ScholarPubMed
Sapolsky, RM. Why stress is bad for your brain. Science 1996;273: 749–750.CrossRefGoogle ScholarPubMed
Patel, R, McIntosh, L, McLaughlin, J, Brooke, S, Nimon, V, Sapolsky, R. Disruptive effects of glucocorticoids on glutathione peroxidase biochemistry in hippocampal cultures. J Neurochem 2002;82: 118–125.DOI: 10.1046/j.1471-4159.2002.00948.xCrossRefGoogle ScholarPubMed
Sherki-Gilgun, Y, Melamed, E, Offen, D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 2001;40: 959–975.DOI: 10.1016/S0028-3908(01)00019-3CrossRefGoogle Scholar
Peet, M, Murphy, B, Shay, J, Horribin, D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998;43: 315–319.DOI: 10.1016/S0006-3223(97)00206-0CrossRefGoogle ScholarPubMed
Cadet, JL. Free radical mechanisms in the central nervous system. An overview. Intern J Neurosci 1988; 40: 13–18. CrossRefGoogle ScholarPubMed
Chen, G. Oxy-radicals toxicity in catecholamine neurons. Neurotoxicology 1984;5: 77–82.Google Scholar